Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway-Reference-Cited by-全球学者库

Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway

Published:2021-06 Issue:14 Volume:12 Page:2093-2103
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Shang Bin¹,Li Zhenxiang²,Li Meng¹,Jiang Shujuan³,Feng Zhen¹,Cao Zhixin⁴,Wang Hui¹^ORCID

Affiliation:

1. Department of Thoracic Surgery Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

2. Department of Radiation Oncology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China

3. Department of Respiratory and Critical Care Medicine Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

4. Department of Pathology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14042

Reference33 articles.

1. Global cancer statistics, 2012

2. Non-small-cell lung cancers: a heterogeneous set of diseases

3. Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression

4. Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches

5. The emerging role of lncRNAs in cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia‐induced factor‐1α promotes radioresistance of esophageal cancer cells by transcriptionally activating LINC01116 and suppressing miR‐3612 under hypoxia;Journal of Biochemical and Molecular Toxicology;2023-11-20

2. Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review);International Journal of Molecular Medicine;2023-06-20

3. LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER− breast cancer samples;Cancer Reports;2023-06-15

4. Psoralidin inhibits osteosarcoma function by down-regulating ITGB1 expression through FAK and PI3K/Akt signaling pathways;2022-11-18

5. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma;Frontiers in Genetics;2022-11-03